Protalix BioTherapeutics (PLX) Return on Assets (2011 - 2026)
Protalix BioTherapeutics (PLX) posted quarterly Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and up 457.28% quarter-over-quarter from 0.0% in Q4 2025.
Protalix BioTherapeutics (PLX) Return on Assets (2011 - 2026) Analysis & Trends
Protalix BioTherapeutics' Return on Assets history runs 15 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q1 2026, with the low at 0.0% in Q1 2022.
- The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Protalix BioTherapeutics' Return on Assets stood at 0.0% in 2022, then surged by 60 bps to 0.0% in 2023, then jumped by 207 bps to 0.0% in 2024, then tumbled by 148 bps to 0.0% in 2025, then surged by 457 bps to 0.0% in 2026.
- Business Quant data shows PLX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.00% |
| 10 | Protalix BioTherapeutics | 191.57 Mn | 150.91 Mn | 12.13 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |